Sarilumab Subcutaneous and High Cholesterol (Hyperlipoproteinemia, Hypertriglyceridemia, Sitosterolemia)
Result of checking the interaction of Sarilumab Subcutaneous and High Cholesterol (Hyperlipoproteinemia, Hypertriglyceridemia, Sitosterolemia) for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug interaction with food or lifestyle.
Consumer:The use of sarilumab is associate with increases in lipid parameters such as LDL cholesterol, HDL cholesterol and/or triglycerides. Care should be exercised when using this agent in patients with lipid abnormalities. It is recommended to assess lipid parameters at baseline and parameters approximately 4 to 8 weeks following initiation of treatment, then at approximately 6 months intervals.
The use of sarilumab is associate with increases in lipid parameters such as LDL cholesterol, HDL cholesterol and/or triglycerides. Care should be exercised when using this agent in patients with lipid abnormalities. It is recommended to assess lipid parameters at baseline and parameters approximately 4 to 8 weeks following initiation of treatment, then at approximately 6 months intervals.
Generic Name: sarilumab
Brand Name: Kevzara, Kevzara Pre-filled Pen
Synonyms: Sarilumab
Sarilumab Subcutaneous - Wysoki cholesterol
(Hyperlipoproteinemia,
Hypertriglyceridemia,
Sitosterolemia) 
Sarilumab Subcutaneous - Colesterol alto (hiperlipoproteinemia, hipertrigliceridemia, sitosterolemia) 
Sarilumab Subcutaneous - Kolesterol tinggi (Hyperlipoproteinemia, Hypertriglyceridemia, Sitosterolemia) 
Sarilumab Subcutaneous - Kolesterol tinggi (Hyperlipoproteinemia, Hipertrigliseridemia, Sitosterolemia) 
Sarilumab Subcutaneous - Alto livello di colesterolo (Iperlipoproteinemia, Ipertrigliceridemia, Sitosterolemia) 
Sarilumab Subcutaneous - Cholestérol élevé (Hyperlipoprotéinémie, Hypertriglycéridémie, Sitostérolémie) 
Sarilumab Subcutaneous - High Cholesterol (Hyperlipoproteinemia, Hypertriglyceridemia, Sitosterolemia) 
Sarilumab Subcutaneous - Colesterol alto (Hiperlipoproteinemia, Hipertrigliceridemia, Sitosterolemia) 
Sarilumab Subcutaneous - Высокий холестерин (Гиперлипопротеинемия, Гипертриглицеридемия, Ситостеролемия) 
Sarilumab Subcutaneous - Yüksek kolesterol (lipoproteinlerin yüksek yoğunluğu, trigliseritlerin yüksek yoğunluğu, sitosterolemi) 
Sarilumab Subcutaneous - كولسترول عالي (فرط شحميات الدم، فرط بروتينات الدم الشحمية) 
Sarilumab Subcutaneous - 高胆固醇 (血脂蛋白过多症、 高甘油三酯血症,、谷固醇血症)